Thousand Oaks biotech company appoints CEO
Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, announced that it has appointed Nima Farzan to be its CEO. Announced July 22, Farzan brings a “strong track record” with more than two decades of leadership experience in the biopharmaceutical industry. Farzan is also Latigo’s first CEO as he replaces Desmond Padhi, operating partner Read More →
Takeda gives life to Moorpark biolab
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Moorpark membrane maker closes seed round of funding
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Port of Hueneme clears the air with new website
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Port aims to be nation’s first zero-emissions port
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Semtech abruptly replaces CEO, stock falls
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
